BPC January 12 update

Immuron IMRN $4.45m DoD deal; Evofem EVFM Phexxi Guidance

Pre-Market Updates

Notable JPM presentations for Wednesday, January 12, 2022: GBIO IMGN EDIT LVTX NTLA MYOV BLUE RPTX

Immuron Limited (NASDAQ: IMRN) announced the funding of a new research agreement with the U.S Department of Defense totaling $4.45 million to evaluate Travelan for military use.

Evofem Biosciences, Inc. (NASDAQ: EVFM) announced that the Health Resources and Services Administration (HRSA) and the U.S. Department of Labor released new guidance regarding its contraceptive product Phexxi. The guidance stated that insurers must cover FDA-approved contraceptives with no out-of-pocket costs to women.

Biogen, Inc. (NASDAQ: BIIB) shares are trading lower in the pre-market after Medicare officials ruled that it plans to cover its Alzheimer’s drug Aduhelm, but only for certain patients enrolled in clinical trials.

Jaguar Health, Inc. (NASDAQ: JAGX) ticked up in the pre-market, following a 13G filing from Oasis Capital showing a 9.99% stake in the company.

Atai Life Sciences N.V. (NASDAQ: ATAI) said the FDA gave investigational new drug (IND) clearance to conduct a clinical drug-drug interaction study of PCN-101 (R-ketamine).

Artelo Biosciences, Inc. (NASDAQ: ARTL) announced that the United Kingdom’s Home Office classified its lead clinical cannabinoid, ART27.13, as “non-controlled” and, therefore, is no longer considered a Schedule 1 controlled substance, which would impose limitations on its production, possession, and supply.

Pre-Market Advancers

CompanyPriceChange
CGTX
Cognition Therapeutics Inc.
$4.30+0.8  +22.86%
HOOK
HOOKIPA Pharma Inc.
$1.79+0.29  +19.33%
MRKR
Marker Therapeutics Inc.
$0.71+0.11  +18.33%
IMMX
Immix Biopharma Inc.
$5.31+0.8  +17.74%
BSGM
BioSig Technologies Inc.
$2.10+0.3  +16.67%
CALA
Calithera Biosciences Inc.
$0.52+0.0678  +14.99%
PALI
Palisade Bio Inc.
$1.21+0.155  +14.69%
RMTI
Rockwell Medical Inc.
$0.45+0.0568  +14.45%
VRPX
Virpax Pharmaceuticals Inc.
$2.63+0.3301  +14.35%
NRBO
NeuroBo Pharmaceuticals Inc.
$1.28+0.16  +14.29%

Pre-Market Decliners

CompanyPriceChange
ARDS
Aridis Pharmaceuticals Inc.
$1.32-0.28  -17.50%
HILS
Hillstream BioPharma Inc.
$2.89-0.47  -13.99%
CINC
CinCor Pharma Inc.
$15.66-2.54  -13.96%
RUBY
Rubius Therapeutics Inc.
$6.54-0.7615  -10.43%
GMDA
Gamida Cell Ltd.
$2.95-0.29  -8.95%
KPTI
Karyopharm Therapeutics Inc.
$7.63-0.65  -7.85%
BDSI
BioDelivery Sciences International Inc.
$3.10-0.26  -7.74%
ITCI
Intra-Cellular Therapies Inc.
$39.57-3.09  -7.24%
BNTC
Benitec Biopharma Inc.
$2.31-0.18  -7.23%
VAXX
Vaxxinity Inc.
$7.57-0.59  -7.23%